| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.028 | 0.9 |